Endoprosthesis revision in cancer patients. MRRC experience
Abstract
In more than 80% of cases of primary and metastatic bone tumors with a modern integrated approach to treatment, it is possible to perform organ-sparing intervention for resection with joint replacement. The frequency of revision interventions for various complications, according to various sources, is from 5 to 50%. The article provides an analysis of the results of arthroplasty and revision arthroplasty for primary and metastatic bone tumors in the A.F. Tsyba MRRC for the period from 2012 to 2018. Background. With advances in combined modality therapy for osseous malignancies, it has become possible to perform endoprosthetic joint replacement for limb salvage after bone resection in more than 80% of patients with primary and metastatic bone tumors. According to the literature data, the frequency of revision procedures for various complications is from 5% to 50%. This study presents an analysis of the results of endoprosthetic replacement and endoprosthetic revision for primary and metastatic bone tumors performed in MRRC between 2012 and 2018.
Purpose. To analyze the results of endoprosthetic replacement of large joints in cancer patients and to identify the causes of complications.
Materials and methods. In the years 2012—2018, we performed 248 endoprosthetic replacements for primary and metastatic tumors of the musculoskeletal system including 42 (17%) endoprosthesis revisions. A greater number of revision procedures were done for tumors of the distal femur and the proximal tibia (55% and 22%, respectively).
Results. Revisions were performed for aseptic instability of one of endoprosthesis stems in 19 (45.2%) cases, for infectious complications in 10 (23.8%), for breakage of the components of the endoprosthesis in 6 (14.3%), and for periprosthetic fractures in 2 (4.8%) cases. Endoprostheses were built up 5 times (11.9 %) due to recurrent disease.
Conclusion. Endoprosthesis revision is one of the most important challenges in orthopedic oncology indicating the need for an individualized approach. Revision procedures are extremely complex due to deficiency of intact bone tissue and surrounding soft tissue, as well as due to infected endoprosthesis bed most often requiring two-stage surgical interventions.
About the Authors
A. A. KurilchikRussian Federation
Kaluga region, 249036, Obninsk, Korolev str., 4.
A. L. Starodubtsev
Russian Federation
Kaluga region, 249036, Obninsk, Korolev str., 4.
A. L. Zubarev
Russian Federation
Kaluga region, 249036, Obninsk, Korolev str., 4.
V. E. Ivanov
Russian Federation
Kaluga region, 249036, Obninsk, Korolev str., 4.
D. V. Kudryavtsev
Russian Federation
Kaluga region, 249036, Obninsk, Korolev str., 4.
References
1. Sostoyaniye onkologicheskoy pomoshchi naseleniyu Rossii v 2016 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, G.V. Petrovoy. M., 2017:236 (In Russ.).
2. Aliyev MD. Zlokachestvennyye opukholi kostey. Sarkomy kostey, myagkikh tkaney i opukholi kozhi. 2010;(2):3-8 (In Russ.).
3. Sokolovskiy AV, Sokolovskiy VA, Badyrov RN, Aliyev MD. Pervyy opyt diafizsokhranyayushchego total'nogo endoprotezirovaniya bedrennoy kosti. Klinicheskiy sluchay. Sarkomy kostey, myagkikh tkaney i opukholi kozhi. 2017;(3):43-49 (In Russ.).
4. Kuril'chik AA, Zubarev AL, Starodubtsev AL, Kudryavtseva GT, Mardynskiy YuS. Rukovodstvo dlya vrachey. Terapevticheskaya radiologiya. Pod red. akademika RAMN, professora A.F. Tsyba, chlena-korrespondenta RAMN, professora Yu.S. Mardynskogo. M., 2010:189-212 (In Russ.).
5. Aliev MD. Modern orthopaedical treatment of metastatic lesion of long bones. M.D. Aliev, V. Teplyakov, L. Sicheva, V. Karpenko. 17th Annual Meeting of the EMSOS, Oslo, Norway, 9-11 June. 2004:46.
6. Trapeznikov NN, Aliev MD, Sokolovskij VA i soavt. Ispol'zo-vanie novyh materialov i tekhnologij pri endoprotezirovanii bol'nyh s opuholyami kostej. V kn.: Pervyj internacional'nyj simpozium plasticheskoj i rekonstruktivnoj hirurgii v onkologii. M., 1997:84 (In Russ.).
7. Aliyev MD, Sokolovskiy VA, Dmitriyeva NV i soavt. Oslozhneniya pri endoprotezirovanii bol'nykh s opukholyami kostey. Vestnik RONTS im. N.N. Blokhina RAMN. 2003;2(1):35-39 (In Russ.).
8. Cannon SR. Massive hrostheses for malignant bone tumors of the limbs. J Bone Joint Surg. 1997;B:90-100.
9. Myers GJ, Abudu AT, Carter SR et al. The long-term results of endoprosthetic replacements of the proximal tibia for bone tumors. J Bone Joint Surg. 2007;89(12):1632-1627.
10. Capanna R, Campanacci DA, Belot N, Beltrami G, Man-frini M et all. A new reconstructive technique for intercalary defects of long bones: the association of massive allograft with vascularized fibular autograft. Long-term results and comparison with alternative techniques. Orthop Clin North Am. 2007;38(1):51-60.
11. Babalayev AA, Sokolovskiy VA. Reendopro-tezirovaniye posle organosokhrannykh operatsiy u bol'nykh opukholyami kostey. Sarkomy kostey, myagkikh tkaney i opukholi kozhi. 2011;(3):23-28 (In Russ.).
12. Ong KL, Lau E, Suggs J, Kurtz SM, Manley MT. Risk of subsequent revision after primary and revision total joint arthroplasty. Clin Orthop. 2010;468(11):3070-3076.
13. Capanna R, Morris HG, Campanacci DA, Del Ben M, Campanacci M. Modular uncemented prosthetic reconstruction after resection of tumors of the distal femur. J Bone Joint Surg. 1994;76B:178-186.
Review
For citations:
Kurilchik A.A., Starodubtsev A.L., Zubarev A.L., Ivanov V.E., Kudryavtsev D.V. Endoprosthesis revision in cancer patients. MRRC experience. Bone and soft tissue sarcomas, tumors of the skin. 2019;11(3):35-41. (In Russ.)